GSK/$GSK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Ticker
$GSK
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
68,629
ISIN
US37733W2044
Website
GSK Metrics
BasicAdvanced
$83B
40.47
$1.03
0.27
$1.53
4.05%
Price and volume
Market cap
$83B
Beta
0.27
52-week high
$44.67
52-week low
$31.72
Average daily volume
5.3M
Dividend rate
$1.53
Financial strength
Current ratio
0.868
Quick ratio
0.575
Long term debt to equity
120.653
Total debt to equity
134.993
Dividend payout ratio (TTM)
78.91%
Interest coverage (TTM)
10.32%
Management effectiveness
Return on assets (TTM)
6.55%
Return on equity (TTM)
27.10%
Valuation
Price to earnings (TTM)
40.474
Price to revenue (TTM)
3.988
Price to book
4.38
Price to tangible book (TTM)
-6.86
Price to free cash flow (TTM)
31.019
Dividend yield (TTM)
3.68%
Forward dividend yield
4.05%
Growth
Revenue change (TTM)
2.57%
Earnings per share change (TTM)
-30.07%
3-year revenue growth (CAGR)
5.66%
3-year earnings per share growth (CAGR)
-15.47%
3-year dividend per share growth (CAGR)
-12.88%
What the Analysts think about GSK
Analyst ratings (Buy, Hold, Sell) for GSK stock.
GSK Financial Performance
Revenues and expenses
GSK Earnings Performance
Company profitability
GSK News
AllArticlesVideos
Dow Jones Industrial Average (DIA) Live June 3: OECD Cuts US GDP Forecast, DIA Dives
24/7 Wall Street·22 hours ago
Carat Group's Fred Hassan dives into what pharma companies to watch at 2025 ASCO Annual Meeting
CNBC Television·5 days ago
Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?
Benzinga·7 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul10
GSK
Dividend·Payment
$0.429088Per share
FAQs
What’s the current market cap for GSK stock?
GSK (GSK) has a market cap of $83B as of June 04, 2025.
What is the P/E ratio for GSK stock?
The price to earnings (P/E) ratio for GSK (GSK) stock is 40.47 as of June 04, 2025.
Does GSK stock pay dividends?
Yes, the GSK (GSK) stock pays dividends to shareholders. As of June 04, 2025, the dividend rate is $1.53157 and the yield is 4.05%. GSK has a payout ratio of 78.91% on a trailing twelve-month basis.
When is the next GSK dividend payment date?
The next GSK (GSK) dividend payment is scheduled for July 10, 2025.
What is the beta indicator for GSK?
GSK (GSK) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.